225 related articles for article (PubMed ID: 11301829)
1. Gene therapy for head and neck cancers.
Lamont JP; Kuhn JA; Nemunaitis JJ; McCarty TM
Oncology (Williston Park); 2001 Mar; 15(3):303-8; discussion 311-4. PubMed ID: 11301829
[TBL] [Abstract][Full Text] [Related]
2. Current role of gene therapy in head and neck cancer.
Ganly I; Soutar DS; Kaye SB
Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
[TBL] [Abstract][Full Text] [Related]
3. Clinical trails referral resource. Clinical trials of adenovirus-p53 gene therapy.
Zwiebel JA; Nagler C; Smiley JK; Cheson BD
Oncology (Williston Park); 1998 Aug; 12(8):1172, 1175. PubMed ID: 11236309
[No Abstract] [Full Text] [Related]
4. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
Overholt SM; Liu TJ; Taylor DL; Wang M; El-Naggar AK; Shillitoe E; Adler-Storthz K; John LS; Zhang WW; Roth JA; Clayman GL
Clin Cancer Res; 1997 Feb; 3(2):185-91. PubMed ID: 9815671
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
Edelman J; Edelman J; Nemunaitis J
Curr Opin Mol Ther; 2003 Dec; 5(6):611-7. PubMed ID: 14755887
[TBL] [Abstract][Full Text] [Related]
6. [Gene therapy and molecular therapeutic for head and neck cancer].
Tanaka H
Gan To Kagaku Ryoho; 2005 Dec; 32(13):2046-51. PubMed ID: 16352927
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers.
Clayman GL; Frank DK; Bruso PA; Goepfert H
Clin Cancer Res; 1999 Jul; 5(7):1715-22. PubMed ID: 10430074
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model.
Eicher SA; Clayman GL; Liu TJ; Shillitoe EJ; Storthz KA; Roth JA; Lotan R
Clin Cancer Res; 1996 Oct; 2(10):1659-64. PubMed ID: 9816113
[TBL] [Abstract][Full Text] [Related]
9. [Treatment for recurrent head and neck carcinomas].
Tsukuda M
Gan To Kagaku Ryoho; 1998 Feb; 25(3):303-8. PubMed ID: 9492820
[TBL] [Abstract][Full Text] [Related]
10. Treatment of recurrent and advanced stage squamous cell carcinoma of the head and neck.
Arnold DJ; Goodwin WJ; Weed DT; Civantos FJ
Semin Radiat Oncol; 2004 Apr; 14(2):190-5. PubMed ID: 15095264
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of tumor suppressor gene p53 in head and neck tumors].
Preisler V; Kirchner S; Hagen R
HNO; 1997 Sep; 45(9):659-62. PubMed ID: 9417443
[No Abstract] [Full Text] [Related]
12. Squamous cell carcinoma in the head and neck.
Al-Reefy H; Dhar V; Dilkes M
Br J Hosp Med (Lond); 2007 Jul; 68(7):380-3. PubMed ID: 17663315
[TBL] [Abstract][Full Text] [Related]
13. Head and neck cancer: response to p53-based therapeutics.
Nemunaitis J; Nemunaitis J
Head Neck; 2011 Jan; 33(1):131-4. PubMed ID: 20222046
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
Liu TJ; el-Naggar AK; McDonnell TJ; Steck KD; Wang M; Taylor DL; Clayman GL
Cancer Res; 1995 Jul; 55(14):3117-22. PubMed ID: 7606733
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary experience in salvage treatment for advanced recurrent cancers of the head and neck].
Jiang PJ; Xu ZG
Zhonghua Zhong Liu Za Zhi; 1991 Jan; 13(1):58-60. PubMed ID: 1889340
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for head and neck cancer.
Rhee JC; Khuri FR; Shin DM
Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
[TBL] [Abstract][Full Text] [Related]
19. Effect of suicide gene therapy in combination with immunotherapy on antitumour immune response & tumour regression in a xenograft mouse model for head & neck squamous cell carcinoma.
Ambade AV; Joshi GV; Mulherkar R
Indian J Med Res; 2010 Oct; 132():415-22. PubMed ID: 20966520
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for head and neck cancer.
Frank DK
Surg Oncol Clin N Am; 2002 Jul; 11(3):589-606, vi-vii. PubMed ID: 12492081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]